Literature DB >> 18983141

Nicotinic acid receptor agonists.

P Douglas Boatman1, Jeremy G Richman, Graeme Semple.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18983141     DOI： 10.1021/jm800896z

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

1.  Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.

Authors:  Anandan Palani; Ashwin U Rao; Xiao Chen; Xianhai Huang; Jing Su; Haiqun Tang; Ying Huang; Jun Qin; Dong Xiao; Sylvia Degrado; Michael Sofolarides; Xiaohong Zhu; Zhidan Liu; Brian McKittrick; Wei Zhou; Robert Aslanian; William J Greenlee; Mary Senior; Boonlert Cheewatrakoolpong; Hongtao Zhang; Constance Farley; John Cook; Stan Kurowski; Qiu Li; Margaret van Heek; Gangfeng Wang; Yunsheng Hsieh; Fangbiao Li; Scott Greenfeder; Madhu Chintala
Journal:  ACS Med Chem Lett       Date:  2011-11-24       Impact factor: 4.345

2.  Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemia.

Authors:  Jun Qin; Ashwin Rao; Xiao Chen; Xiaohong Zhu; Zhidan Liu; Xianhai Huang; Sylvia Degrado; Ying Huang; Dong Xiao; Robert Aslanian; Boonlert Cheewatrakoolpong; Hongtao Zhang; Scott Greenfeder; Constance Farley; John Cook; Stan Kurowski; Qiu Li; Margaret van Heek; Madhu Chintala; Ganfeng Wang; Yunsheng Hsieh; Fangbiao Li; Anandan Palani
Journal:  ACS Med Chem Lett       Date:  2010-12-08       Impact factor: 4.345

Review 3.  G protein-coupled receptors for energy metabolites as new therapeutic targets.

Authors:  Clara C Blad; Cong Tang; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2012-07-13       Impact factor: 84.694

Review 4.  Progress in structure based drug design for G protein-coupled receptors.

Authors:  Miles Congreve; Christopher J Langmead; Jonathan S Mason; Fiona H Marshall
Journal:  J Med Chem       Date:  2011-06-15       Impact factor: 7.446

5.  Biological roles and therapeutic potential of hydroxy-carboxylic Acid receptors.

Authors:  Kashan Ahmed
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-25       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.